Investigating the comprehensive aPL profile of patients/carriers should be mandatory, as the isolated positivity for LA has not been unanimously associated with thrombosis (12) or with clinical manifestations of APS (13). The gene discussed is FASLG; the disease is autoimmune polyendocrinopathy.